Bleeding Time Study With AZD6482, Clopidogrel & ASA

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Antiplatelet Effect

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04142151` - Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke	N/A
Completed	`NCT02733640` - Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?	N/A
Completed	`NCT00688714` - Study to Investigate Safety and Tolerability of a Single Dose of AZD6482	Phase 1

See also

Status

Clinical Trial

Phase

Recruiting

NCT04142151 - Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

N/A

Completed

NCT02733640 - Does Pantoprazole Reduce the Anti-platelet Effect of Clopidogrel?

N/A

Completed

NCT00688714 - Study to Investigate Safety and Tolerability of a Single Dose of AZD6482

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00853450
Study type	Interventional
Source	AstraZeneca
Contact
Status	Completed
Phase	Phase 1
Start date	February 2009
Completion date	July 2009

Bleeding Time Study With AZD6482, Clopidogrel and ASA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms